Koninklijke Philips N.V.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Roy Willem Odilia Jakobs
- Full Time Employees
- 66,401
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Philips Center Amsterdam NH Netherlands 1077 WV
- IPO Date
- Sep 18, 2009
- Website
- philips.com
- Similar Companies
- Business
- Koninklijke Philips N.V. functions as a global leader in health technology, dedicated to enhancing people's health and well-being through meaningful innovation across various international markets. The company structures its operations across key divisions: Diagnosis & Treatment, Connected Care, and Personal Health. Within its Diagnosis & Treatment segment, Philips provides advanced diagnostic imaging systems such as magnetic resonance (MRI), computed tomography (CT), X-ray, and ultrasound equipment, alongside integrated image-guided therapy solutions and enterprise diagnostic informatics for cardiology, radiology, and oncology. The Connected Care segment focuses on comprehensive patient monitoring solutions for hospitals and home settings, emergency care devices, and sleep and respiratory care products. Notably, the company has been actively addressing a significant voluntary recall issued in June 2021 concerning specific CPAP, BiPAP, and mechanical ventilator devices from its Respironics portfolio, working on remediation efforts for affected users globally. The Personal Health sector offers consumer-focused products, including innovative oral healthcare items like electric toothbrushes, mother and child care solutions, and male grooming and beauty appliances. Philips is deeply committed to digital transformation and artificial intelligence (AI) in healthcare, expanding strategic collaborations with partners like Amazon Web Services (AWS) to integrate cloud services and generative AI into diagnostic workflows. Recent innovations include AI-enhanced solutions for interventional cardiology, such as DeviceGuide, and expanded partnerships for AI-enabled neuroimaging. The company's business model emphasizes driving value through focused organic growth, patient-centric innovation, and a strong commitment to sustainability. Initially established in Eindhoven in 1891, Koninklijke Philips N.V. has evolved significantly, changing its name in May 2013 to reflect its sharpened focus on health technology. The multinational enterprise maintains its headquarters in Amsterdam, the Netherlands.
Company News
Gaming Has Become a Source of Real-World Style Inspiration. The Most Important Character That Gamers Are Customizing?
Philips highlights Integrated Diagnostics' role in the future of cardiovascular informatics following MediReport acquisition
Philips: A Risky Turnaround Worth A 'Strong Buy' Upgrade
EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe
Philips Oral Healthcare Establishes Global Clinical Advisory Board to Help Shape the Future of Oral Care Through Scientific and Clinical Insight
Koninklijke Philips N.V. (NYSE:PHG) Given Average Rating of “Hold” by Brokerages
Southwest Mississippi Regional Medical Center Becomes First U.S. Hospital to Install Philips Rembra CT for Acute and High-Demand Imaging Environments
Philips-led projects win ITEA awards for advancing AI-enabled healthcare innovation
Philips OneBlade and Red Bull take self-expression to new heights in Cappadocia, Turkey
Philips Launches Revolutionary Lumea® IPL 9900 Pro: the First At-Home Intense Pulsed Light (IPL) Hair Removal Device With Real-Time Audio Guidance That Talks to You During Treatment
Philips Expands Women's Health Ultrasound Portfolio With New Transducer
Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC
Philips advances women's health ultrasound with new single-transducer solution
Financial Analysis: Koninklijke Philips (NYSE:PHG) & Microbot Medical (NASDAQ:MBOT)
Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration
Philips and Imricor launch cardiac interventional MR lab solution, expanding longstanding collaboration
Philips selected for ARPA-H program to advance AI-enabled robotic stroke care
Philips prices EU green bond for EUR 650M
Bank of America Corp DE Purchases 50,124 Shares of Koninklijke Philips N.V. $PHG
Philips, Shell targeted by hacking group